FBInvestor
Stocks / Trisalus Life Sciences Inc
Institutional Ownership

Trisalus Life Sciences Inc

CUSIP 89680M101COMTLSIQ1 2026

13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
24.1%
Max % of class reported
Institutional Holders
81
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

22 filings · latest Nov 14, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Nov 14, 2025Nantahala Capital Management, LLC13G/A4.1%2.04MSEC
2Nov 3, 2025Utmost Group PLC13G6.8%3.39MSEC
3Aug 19, 2025Utmost Group PLC13G/A5.2%1.98MSEC
4Aug 18, 2025Utmost Group PLC13G0.1%2.00MSEC
5Aug 14, 2025Nantahala Capital Management, LLC13G5.3%2.00MSEC
6Aug 4, 2025Frankenius Equity Ab13D/A14.0%SEC
7Aug 1, 2025Mats Wahlstrom13D/A6.0%SEC
8May 2, 2025Frankenius Equity Ab13D/A20.5%SEC
9Jan 10, 2025Utmost Group PLC13G6.6%2.00MSEC
10Jan 10, 2025Lombard International Assurance S.A.13GSEC

12 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Trisalus Life Sciences Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →